Replies to post #105639 on Biotech Values

[DewDiligence]

The NYT piece on MON covers no new ground, and it repeats the canard that glyphosate resistance renders MON’s biotech traits less consequential. I’ve previously posted why it doesn’t.

My desire for tomorrow’s earnings report is merely the absence of another reduction in EPS guidance.

[DewDiligence]

MON’s FY2011 EPS Guidance

 
                 FY2011    FY2010   Percent 
                Guidance   Actual   Change 
 Non-GAAP EPS*  2.72-2.82   2.41    13-17% 
 GAAP EPS       2.67-2.77   2.01    33-38% 

*Excludes restructuring charges.

Source: http://monsanto.mediaroom.com/index.php/index.php?s=43&item=884

[DewDiligence]

You asked for a MON bounce…you got it today. The reason makes little sense, however—see #msg-55331287.